Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

Category
Sort Date
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Charting the Course: A Brief Recap of BGTC's Regulatory Playbook for AAV Gene Therapies
Featured
Biomanufacturing

Charting the Course: A Brief Recap of BGTC's Regulatory Playbook for AAV Gene Therapies

Claire Aldridge, PhD

Claire Aldridge, PhD

Discover key strategies and guidelines for compliance in gene therapy research with BGTC's AAV Gene Therapy Regulatory Playbook.

Removing the Multiomics Data Analysis Bottleneck to Advance Life Science Research and Development
Featured
Bioinformatics

Removing the Multiomics Data Analysis Bottleneck to Advance Life Science Research and Development

Chris Haas

Chris Haas

Explore how to navigate the complexities of multiomics data analysis in life science with our innovative solutions that empower researchers and accelerate R&D processes in the field.

Harmonizing AAV Vector Design, AI and Biological Data for Effective Gene Therapy Development
Featured
Artificial Intelligence

Harmonizing AAV Vector Design, AI and Biological Data for Effective Gene Therapy Development

Joe Nipko, PhD

Joe Nipko, PhD

Discover how harmonizing AAV, AI, and biological data is revolutionizing gene therapy development, paving the way for safe and effective treatments.

Optimizing AAV Gene Therapy: Unlocking Efficiency and Quality in the Production Process
Featured
Artificial Intelligence

Optimizing AAV Gene Therapy: Unlocking Efficiency and Quality in the Production Process

Jill Roughan, PhD

Jill Roughan, PhD

See how process optimization for AAV gene therapies ensure higher efficiency and quality in every batch.

From Observational to Predictive: The Pivotal Role of AI in Modern Biological Experimentation
Featured
Artificial Intelligence

From Observational to Predictive: The Pivotal Role of AI in Modern Biological Experimentation

Amicia Elliott, PhD

Amicia Elliott, PhD

Explore the transformative journey from traditional biological lab techniques to AI-augmented scientific methods. Discover how AI is set to reshape biological lab experimentation in gene therapy.

Unlock Greater AAV Vector Design Precision with Accurate PacBio Full-Length Sequencing and Form Bio Tools
Featured
Bioinformatics

Unlock Greater AAV Vector Design Precision with Accurate PacBio Full-Length Sequencing and Form Bio Tools

Nadia Sellami, PhD

Nadia Sellami, PhD

See how PacBio long-read sequencing and Form Bio solutions help optimize AAV vector design, potentially enhancing accuracy and enabling gene therapy manufacturing success.

Gene Therapy 2024: What’s in Store?
Featured
Artificial Intelligence

Gene Therapy 2024: What’s in Store?

Kent Wakeford

Kent Wakeford

We predict these 6 areas of focus that will optimize research, development and personalized medicine to improve gene therapy patient treatment.

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models
Featured
Artificial Intelligence

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Austin Day, PhD

Austin Day, PhD

Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.

Decoding Gene Expression with the Borzoi Model and Potential Use in AAV Gene Therapy Development
Featured
Artificial Intelligence

Decoding Gene Expression with the Borzoi Model and Potential Use in AAV Gene Therapy Development

Austin Day, PhD

Austin Day, PhD

Explore the Borzoi model, a newly published computational tool for predicting gene expression and its potential use in AAV construct design.

Analytical Development and Characterization for Adeno-Associated Virus (AAV) Gene Therapy
Featured
Artificial Intelligence

Analytical Development and Characterization for Adeno-Associated Virus (AAV) Gene Therapy

Jill Roughan, PhD

Jill Roughan, PhD

Learn the essential steps for characterizing your gene therapy product with bioreactor simulator runs in your pre-clinical development stage.

How Can You Integrate AI into Life Science Programs, And When Should You Do It?
Featured
Artificial Intelligence

How Can You Integrate AI into Life Science Programs, And When Should You Do It?

Claire Aldridge, PhD

Claire Aldridge, PhD

Explore the boundless potential at the intersection of life sciences and AI. Discover actionable insights to embark on this journey leveraging cutting-edge technology.

Solving Gene Therapy Product Development Challenges Through AAV Analytical Method Development
Featured
Artificial Intelligence

Solving Gene Therapy Product Development Challenges Through AAV Analytical Method Development

Jill Roughan, PhD

Jill Roughan, PhD

Learn how to overcome product quality challenges when moving from pre-clinical to commercialization of AAV gene therapy.

Form Bio Resources

Board of Directors

Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

John

Doe

,

Ph.D.

CEO
Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

Johnn

Doe

,

Ph.D.

CEO